Renato Bassan

21PUBLICATIONS
66CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Child and adolescent developmentPredictive and prognostic markersPsychological methodology, design and analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Nov 18, 2025
Nilotinib versus imatinib with early switch from imatinib to nilotinib to obtain treatment-free remission in newly diagnosed chronic myeloid leukemia patients: the analysis of the first co-primary endpoint.

Fausto Castagnetti, Massimo Breccia, Elisabetta Abruzzese

|Feb 26, 2025
Up-front blinatumomab improves MRD clearance and outcome in adult Ph- B-lineage ALL: the GIMEMA LAL2317 phase 2 study.

Renato Bassan, Sabina Chiaretti, Irene Della Starza

|Feb 02, 2024
Management of ALL in adults: 2024 ELN recommendations from a European expert panel.

Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti

|Jan 31, 2024
Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel.

Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti

|Dec 21, 2023
Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL.

Robin Foà, Renato Bassan, Loredana Elia

|Dec 19, 2023
A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study.

Amir Enshaei, Melvin Joy, Ellie Butler

Pageof 4

Frequent Collaborators

7 joint publications

Alessandro Rambaldi

6 joint publications

Orietta Spinelli

4 joint publications

Josep-Maria Ribera

4 joint publications

Alfonso Piciocchi